Multicenter Study on the Long-Term (3-Year) Efficacy of Lanthanum Carbonate in Dialysis Patients

被引：0

作者：

Ando, Ryoichi ^{[1
]}

Yama, Satomi ^{[1
]}

Ohnishi, Tsuyoshi ^{[1
]}

Iwamoto, Shunsuke ^{[1
]}

Kimura, Hitoshi ^{[1
]}

Chida, Yoshiko ^{[2
]}

Ishida, Yuji ^{[3
]}

Yamada, Kouei ^{[4
]}

Inagaki, Yuichiro ^{[4
]}

Takayama, Masanobu ^{[5
]}

Tachibana, Ken ^{[6
]}

Kikuchi, Kan ^{[7
]}

Inoue, Atsushi ^{[7
]}

Ohtsuka, Masakazu ^{[8
]}

机构：

[1] Musashino Red Cross Hosp, Dept Nephrol, Tokyo, Japan

[2] Nakano Clin, Tokyo, Japan

[3] Kyonan Clin, Tokyo, Japan

[4] Kichijoji Ekimae Clin, Tokyo, Japan

[5] Takayama Clin, Tokyo, Japan

[6] Tachibana Clin, Tokyo, Japan

[7] Shimo Ochiai Clin, Tokyo, Japan

[8] Tokiwa Clin, Toride, Ibaraki, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2014年 / 18卷

关键词：

Lanthanum Carbonate; Long-Term Effects; Management Target Values; Multicenter Study; CHRONIC KIDNEY-DISEASE; MORTALITY RISK; SERUM-CALCIUM; HEMODIALYSIS-PATIENTS; PHOSPHATE; HYPERPHOSPHATEMIA; PTH;

D O I：

10.1111/1744-9987.12206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We previously conducted a multicenter study enrolling 101 dialysis patients with hyperphosphatemia in which lanthanum carbonate (LC) was administered for 2 years. In this study, the administration has been continued for an additional year, and we have evaluated the long-term (a total of 3 years) effects of LC. The average serum phosphorus (P) level was 6.05 mg/dL at the start and decreased to 5.84 mg/dL after 3 years, but no significant differences were observed at both points. The average serum corrected calcium (Ca) level significantly reduced after 3 years (P < 0.001). As results of evaluating the achievement rates with the management target values of serum P, Ca and intact parathyroid hormone (PTH) stated in the Japanese guideline, the achievement rates increased after 3 years. From these results, LC is considered to be a useful P binder that can be used for long-term treatment of hyperphosphatemia, without causing a Ca load.

引用

页码：2 / 8

页数：7

共 14 条

[1] Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients
Albaaj, F
Hutchison, AJ
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (02) : 319 - 328
[2] Multicenter Study of Long-Term (Two-Year) Efficacy of Lanthanum Carbonate
Ando, Ryoichi
Kimura, Hitoshi
Sato, Hidehiko
Iwamoto, Shunsuke
Yoshizaki, Yuki
Chida, Yoshiko
Ishida, Yuji
Takayama, Masanobu
Yamada, Kouei
Tachibana, Ken
Ohtsuka, Masakazu
Kikuchi, Kan
Inoue, Atsushi
[J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 : 2 - 8
[3] Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
Blacher, J
Guerin, AP
Pannier, B
Marchais, SJ
London, GM
[J]. HYPERTENSION, 2001, 38 (04) : 938 - 942
[4] Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
Block, GA
Klassen, PS
Lazarus, JM
Ofsthun, N
Lowrie, EG
Chertow, GM
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2208 - 2218
[5] Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
Fukagawa, Masafumi
Yokoyama, Keitaro
Koiwa, Fumihiko
Taniguchi, Masatomo
Shoji, Tetsuo
Kazama, Junichiro James
Komaba, Hirotaka
Ando, Ryoichi
Kakuta, Takatoshi
Fujii, Hideki
Nakayama, Msasaaki
Shibagaki, Yugo
Fukumoto, Seiji
Fujii, Naohiko
Hattori, Motoshi
Ashida, Akira
Iseki, Kunitoshi
Shigematsu, Takashi
Tsukamoto, Yusuke
Tsubakihara, Yoshiharu
Tomo, Tadashi
Hirakata, Hideki
Akizawa, Tadao
[J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (03) : 247 - 288
[6] Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131
[7] Long-term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment
Hutchison, Alastair J.
Barnett, M. Edwina
Krause, Rolfdieter
Kwan, Jonathan T. C.
Siami, Ghodrat A.
[J]. NEPHRON CLINICAL PRACTICE, 2008, 110 (01): : C15 - C23
[8] Serum phosphate levels and mortality risk among people with chronic kidney disease
Kestenbaum, B
Sampson, JN
Rudser, KD
Patterson, DJ
Seliger, SL
Young, B
Sherrard, DJ
Andress, DL
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02): : 520 - 528
[9] Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study
Melamed, M. L.
Eustace, J. A.
Plantinga, L.
Jaar, B. G.
Fink, N. E.
Coresh, J.
Klag, M. J.
Powe, N. R.
[J]. KIDNEY INTERNATIONAL, 2006, 70 (02) : 351 - 357
[10] Shigematsu T, 2008, CLIN NEPHROL, V70, P404

← 1 2 →